tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
DMAC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsDMAC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
21d ago
DiaMedica Therapeutics CMO Lorianne Masuoka resigns, Julie Krop succeeds
Premium
The Fly
DiaMedica Therapeutics CMO Lorianne Masuoka resigns, Julie Krop succeeds
25d ago
DiaMedica Appoints New Chief Medical Officer
Premium
Company Announcements
DiaMedica Appoints New Chief Medical Officer
25d ago
DiaMedica Announces $30.1M Private Placement for DM199
PremiumCompany AnnouncementsDiaMedica Announces $30.1M Private Placement for DM199
1M ago
DiaMedica Therapeutics price target raised to $11 from $8 at Craig-Hallum
Premium
The Fly
DiaMedica Therapeutics price target raised to $11 from $8 at Craig-Hallum
1M ago
DiaMedica Therapeutics price target raised to $14 from $11 at Lake Street
Premium
The Fly
DiaMedica Therapeutics price target raised to $14 from $11 at Lake Street
1M ago
DiaMedica Therapeutics to be included in Russell 2000, 3000 Indexes
PremiumThe FlyDiaMedica Therapeutics to be included in Russell 2000, 3000 Indexes
2M ago
Promising Potential of Diamedica Therapeutics’ DM199 in Preeclampsia Treatment Drives Buy Rating
Premium
Ratings
Promising Potential of Diamedica Therapeutics’ DM199 in Preeclampsia Treatment Drives Buy Rating
3M ago
DiaMedica Therapeutics’ Earnings Call Highlights Progress and Stability
Premium
Company Announcements
DiaMedica Therapeutics’ Earnings Call Highlights Progress and Stability
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100